BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11191348)

  • 1. Inducible resistance to Fas-mediated apoptosis in B cells.
    Rothstein TL
    Cell Res; 2000 Dec; 10(4):245-66. PubMed ID: 11191348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-specific regulation of B-cell susceptibility to Fas-mediated apoptosis and a novel Fas apoptosis inhibitory molecule.
    Rothstein TL; Zhong X; Schram BR; Negm RS; Donohoe TJ; Cabral DS; Foote LC; Schneider TJ
    Immunol Rev; 2000 Aug; 176():116-33. PubMed ID: 11043772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic deletion of faim reveals its role in modulating c-FLIP expression during CD95-mediated apoptosis of lymphocytes and hepatocytes.
    Huo J; Xu S; Guo K; Zeng Q; Lam KP
    Cell Death Differ; 2009 Jul; 16(7):1062-70. PubMed ID: 19300454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.
    Wieckowski E; Atarashi Y; Stanson J; Sato TA; Whiteside TL
    J Cell Biochem; 2007 Jan; 100(1):16-28. PubMed ID: 16888780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.
    Moriyama H; Yonehara S
    Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells.
    Foote LC; Schneider TJ; Fischer GM; Wang JK; Rasmussen B; Campbell KA; Lynch DH; Ju ST; Marshak-Rothstein A; Rothstein TL
    J Immunol; 1996 Sep; 157(5):1878-85. PubMed ID: 8757305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren's syndrome.
    Ping L; Ogawa N; Sugai S
    Arthritis Rheum; 2005 Feb; 52(2):573-81. PubMed ID: 15692983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-x protects primary B cells against Fas-mediated apoptosis.
    Schneider TJ; Grillot D; Foote LC; Núñez GE; Rothstein TL
    J Immunol; 1997 Nov; 159(10):4834-9. PubMed ID: 9366408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells.
    Afford SC; Ahmed-Choudhury J; Randhawa S; Russell C; Youster J; Crosby HA; Eliopoulos A; Hubscher SG; Young LS; Adams DH
    FASEB J; 2001 Nov; 15(13):2345-54. PubMed ID: 11689460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP.
    Wang J; Lobito AA; Shen F; Hornung F; Winoto A; Lenardo MJ
    Eur J Immunol; 2000 Jan; 30(1):155-63. PubMed ID: 10602037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2.
    Poulaki V; Mitsiades N; Romero ME; Tsokos M
    Cancer Res; 2001 Jun; 61(12):4864-72. PubMed ID: 11406564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis.
    Zhang X; Li L; Choe J; Krajewski S; Reed JC; Thompson C; Choi YS
    Cell Immunol; 1996 Oct; 173(1):149-54. PubMed ID: 8871610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
    Amanullah A; Liebermann DA; Hoffman B
    Oncogene; 2002 Feb; 21(10):1600-10. PubMed ID: 11896589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
    Moreno MB; Memon SA; Zacharchuk CM
    J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
    Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
    Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappa B is required for surface Ig-induced Fas resistance in B cells.
    Schram BR; Rothstein TL
    J Immunol; 2003 Mar; 170(6):3118-24. PubMed ID: 12626568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
    Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.